CEPHAPIRIN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Cephapirin Sodium patents expire, and what generic alternatives are available?
Cephapirin Sodium is a drug marketed by Abraxis Pharm and Hikma and is included in two NDAs.
The generic ingredient in CEPHAPIRIN SODIUM is cephapirin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephapirin sodium profile page.
Summary for CEPHAPIRIN SODIUM
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 44 |
Clinical Trials: | 1 |
Patent Applications: | 1,358 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CEPHAPIRIN SODIUM at DailyMed |
Recent Clinical Trials for CEPHAPIRIN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Federal University of São Paulo | Phase 4 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |